Suicidal Poisoning in Emergency Units

NCT ID: NCT04217070

Last Updated: 2024-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

303 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Poisoning is the deterioration of the body's functions by the ingestion of any substance being toxic to the body or by overdosing a nontoxic substance. Poisoning cases may vary according to the geographical and seasonal characteristics of the region, sociocultural structure of the population, life index and the age groups.

Worldwide, intentional self-poisoning (ISP) is the most common form of suicide attempt and the most common method that results in medical hospitalization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Questionnaire is prepared including the following items:

Demographic data:

Gender -age-marital status -occupation- socioeconomic state -special habit -history of psychiatric innless-history of chronic diseases-history of drug dependence -previous suicidal attempts-toxic substance used in suicide- time of poisoning, season and time of arrival .

Data regarding poisoned substance:

Dose, type of the substance used and rout of administration. Presenting symptoms of intoxication and management

Complete clinical examination:

General condition: conscious level and vital signs. Local examination: chest, heart, abdomen, etc.

Investigation:

(Arterial blood gases - ECG -otherwise according to case presentation)

Prognosis:

Complete recovery, complications, death.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Poisoning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Questionnaire including demographic data, data regarding poisoning substance and outcomes of suicidal attempts

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ABG, ECG, ECHO, SCREENING TESTS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* suicidal poisoning cases

Exclusion Criteria

* other causes of suicide
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gehad Hussien Eisa

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Randa H Abd-Elhady, prof

Role: STUDY_DIRECTOR

Noha E Ebrahem, Dr

Role: STUDY_DIRECTOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University Hospital

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Conner KR, Wiegand TJ, Gorodetsky R, Schult RF, Kaukeinen K. Poisoning Severity Associated with a Range of Medications in Suicide Attempts by Ingestion. Suicide Life Threat Behav. 2019 Jun;49(3):635-642. doi: 10.1111/sltb.12468. Epub 2018 Apr 25.

Reference Type BACKGROUND
PMID: 29693268 (View on PubMed)

Kanchan T, Menezes RG. Suicidal poisoning in Southern India: gender differences. J Forensic Leg Med. 2008 Jan;15(1):7-14. doi: 10.1016/j.jflm.2007.05.006. Epub 2007 Sep 5.

Reference Type BACKGROUND
PMID: 18096509 (View on PubMed)

Kazanasmaz H, Kazanasmaz O, Calik M. Epidemiological and sociocultural assessment of childhood poisonings. Turk J Emerg Med. 2019 Jun 20;19(4):127-131. doi: 10.1016/j.tjem.2019.06.001. eCollection 2019 Oct.

Reference Type BACKGROUND
PMID: 31687610 (View on PubMed)

Piekarska-Wijatkowska A, Kobza-Sindlewska K, Rogaczewska A, Zajdel R, Krakowiak A. Intentional poisoning among elderly people-residents of a large urban agglomeration in Poland. Hum Exp Toxicol. 2016 Dec;35(12):1328-1336. doi: 10.1177/0960327116630353. Epub 2016 Feb 9.

Reference Type BACKGROUND
PMID: 26860687 (View on PubMed)

Klonsky ED, May AM, Saffer BY. Suicide, Suicide Attempts, and Suicidal Ideation. Annu Rev Clin Psychol. 2016;12:307-30. doi: 10.1146/annurev-clinpsy-021815-093204. Epub 2016 Jan 11.

Reference Type BACKGROUND
PMID: 26772209 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESPEUAUH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Allopurinol to Prevent Cirrhosis Related Morbidities
NCT05545670 COMPLETED PHASE2/PHASE3
Alcohol, Gut Leakiness, & Liver Disease
NCT05428072 COMPLETED EARLY_PHASE1
Allopurinol and Quality of Life in Liver Cirrhosis
NCT05828836 COMPLETED PHASE2/PHASE3